-
Financial
Xtant Medical Announces First Quarter 2019 Financial Results
BELGRADE, Mont., May 15, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Bone Therapeutics Provides First Quarter 2019 Business Update
Gosselies, Belgium, 7 May 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high…
Read More » -
Spine
Alphatec Announces Commercial Launch of PLIF IdentiTi™ Posterior Straight Porous Titanium Interbody System Implant and AlphaGRAFT® DBM Fiber
CARLSBAD, Calif., May 06, 2019 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device…
Read More » -
Financial
Anika Reports First Quarter 2019 Financial Results
May 02, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Financial
SeaSpine Reports First Quarter 2019 Financial Results
CARLSBAD, Calif., May 01, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
Anika Appoints Stephen Goldy as Vice President of U.S. Sales
April 30, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Extremities
In2Bones Announces the Global Launch of the TriWay® TibioTaloCalcaneal (TTC) Nail Arthrodesis System
April 30, 2019 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announced the global launch of the TriWay® TibioTaloCalcaneal (TTC) Nail Arthrodesis System. Developed by…
Read More » -
Financial
Zimmer Biomet Announces First Quarter 2019 Financial Results
WARSAW, Ind., April 26, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31,…
Read More » -
Biologics
Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Its Wound Healing Matrix
April 18, 2019 MADISON, Wis.–(BUSINESS WIRE)–Imbed Biosciences Inc. (Imbed), a medical device company emerging as a leader in the development…
Read More » -
Biologics
Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix
OAKLAND, N.J., April 12, 2019 /PRNewswire/ — Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral…
Read More » -
Biologics
ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products
COLUMBIA, Md., April 8, 2019 /PRNewswire/ — ACell, Inc. today announced that it has entered into an exclusive long-term product supply and…
Read More » -
Financial
Medacta opens IPO-Season 2019 at Six
Date 04/04/2019 Today, the shares of Medacta Group SA (ticker „MOVE“) were traded for the first time at SIX, opening at…
Read More »